Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?

To: Beltropolis Boy who wrote (558)	1/22/1999 2:39:00 PM
From: Beltropolis Boy	Read Replies (1) \| Respond to of 828

TheStreet.com's MIDDAY UPDATE Jan. 22, 1999 Herb on TheStreet By Herb Greenberg Senior Columnist *More Safeskin: An item yesterday suggested the company (SFSK:Nasdaq) hadn't been conservative when it took a charge in 1996 for action that won't occur until early next year. Several CPAs wrote in saying that CFO David Morash's explanation, that the charge merely became a noncash reserve, was appropriate. And Morash himself yesterday said he thought he was being conservative by not reversing the charge, as the column suggested he should've done. The column said that by not reversing the charge, the company benefited from a lower valuation on its assets and, in turn, less depreciation, which would have the effect of boosting gross margins. Morash, however, says that had the charge been taken, about half would have been for severance, with the writedown of machinery only accounting for $750,000. Based on eight to 10 years of depreciation, "that would add maybe $100,000 a year in gross margin, which is less than one-tenth of one percent of our gross margin." Considering that the company's gross margins have jumped to 52% from 32%, "that's not even a poke in the eye."